Results 111 to 120 of about 19,704 (200)

Combination therapy in hypertension: An update [PDF]

, 2010
Sanjay Kalra, Bharti Kalra, Navneet Agrawal   +2 more
core   +1 more source

Telmisartan protects male reproductive function by modulating biochemical, oxidative stress, apoptosis, and DNA integrity in cyclophosphamide-exposed rats. [PDF]

Toxicol Rep
Kassid AA, Mahmood AM, Obaid KA, Philip Rahmani MH.   +3 more
europepmc   +1 more source

Comparative effectiveness of telmisartan vs. other angiotensin receptor blockers in reducing hypertension-related cerebrovascular and cardiovascular events: a real-world retrospective study using the TriNetX network. [PDF]

Front Cardiovasc Med
Chen TY, Lin YC, Liu GY, Hung HC.
europepmc   +1 more source

Comparison of efficacy of Long-Term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease [PDF]

Danyel LA, DiBartola SP, Dow SW, Ladino M, Matsuo T, Polzin DJ, Polzin DJ, Polzin DJ, Westfall PTRaWR   +8 more
core   +1 more source

Effect of Ang II Receptor Inhibition on GSK-3β/CREB/BDNF Signalling in REM Sleep Deprivation-Induced Memory Impairment. [PDF]

Neurochem Res
Elma N, Sayan Özaçmak H, Turan İ.
europepmc   +1 more source

Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study [PDF]

, 2013

core   +1 more source

Newly Synthesized Telmisartan-Amino Acid Conjugates Exhibit Enhanced Cytotoxic Effects in Malignant Melanoma Cells. [PDF]

Molecules
Vukadinović D, Damjanović A, Vuković M, Čudina O, Grahovac J, Dobričić V.   +5 more
europepmc   +1 more source

Efficacy of finerenone in reducing proteinuria in diabetic kidney disease with maximum tolerable doses of dapagliflozin and telmisartan. [PDF]

World J Nephrol
Pasari AS, Gupta S, Gurjar P, Ramteke V, Malde S, Pawar T, Jeyachandran V, Kashiv P, Dubey S, Kurundwadkar M, Sejpal K, Bawankule C, Deshpande N, Balwani MR.   +13 more
europepmc   +1 more source

Assessing Renoprotective Effects of Empagliflozin and Telmisartan Combination Therapy in Non-albuminuric Diabetic Nephropathy: A Retrospective Cohort Study. [PDF]

Cureus
Acharya A, Kotakala CMK, Kodanda Ramu B, Padala T, Aditya Reddy P, Patnaik PK, Niharika Mede B.   +6 more
europepmc   +1 more source

Dual-Targeted Therapy in Cardiometabolic Risk: A Meta-Analysis of Telmisartan-Based Combinations for Hypertension and Dyslipidemia. [PDF]

Clin Cardiol
Asim R, Muhammad TS, Ahmed S, Khurram L, Azeem B, Doggar ME, Muhammad AN, Chikatimalla R, Kapaganti S, Chigurupati HD, Qureshi B, Sandhyavenu H, Neppala S.   +12 more
europepmc   +1 more source